Tidal Investments’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-138,276
Closed -$731K 2646
2026
Q1
$731K Buy
+138,276
New +$798K ﹤0.01% 1655

Other funds holding CMPX

Tidal Investments's CMPX Position: Q2 2026 in Review

Tidal Investments sold out of Compass Therapeutics (CMPX) in Q2 2026, closing a stake of 138,276 shares — an estimated $731K sold.

Tidal Investments first reported a position in CMPX in Q1 2026 and held it in 1 quarter. The position peaked at $731K in Q1 2026. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Tidal Investments reported no remaining Compass Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Tidal Investments sold 138,276 Compass Therapeutics shares in Q2 2026, an estimated $731K.
  • Tidal Investments first reported a position in Compass Therapeutics in Q1 2026 and held it in 1 quarter.
  • Tidal Investments's Compass Therapeutics position peaked at $731K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.